Enzo Biochem Inc
NYSE:ENZ
Enzo Biochem Inc
Net Income (Common)
Enzo Biochem Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Enzo Biochem Inc
NYSE:ENZ
|
Net Income (Common)
-$4.6m
|
CAGR 3-Years
24%
|
CAGR 5-Years
28%
|
CAGR 10-Years
11%
|
|
DaVita Inc
NYSE:DVA
|
Net Income (Common)
$691.5m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
34%
|
CAGR 10-Years
1%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Net Income (Common)
$842m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
3%
|
CAGR 10-Years
0%
|
|
CVS Health Corp
NYSE:CVS
|
Net Income (Common)
$7.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
Cigna Corp
NYSE:CI
|
Net Income (Common)
$5.2B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Net Income (Common)
$433.1m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-2%
|
See Also
What is Enzo Biochem Inc's Net Income (Common)?
Net Income (Common)
-4.6m
USD
Based on the financial report for Jan 31, 2024, Enzo Biochem Inc's Net Income (Common) amounts to -4.6m USD.
What is Enzo Biochem Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
11%
Over the last year, the Net Income (Common) growth was 87%. The average annual Net Income (Common) growth rates for Enzo Biochem Inc have been 24% over the past three years , 28% over the past five years , and 11% over the past ten years .